Aclaris Therapeutics (ACRS) Q2 2025 Earnings

May 8Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.01
-0.68
-0.34
-0.01

Details

Expected EPS
-0.152204
Actual EPS
-0.12
Surprise EPS
0.03
Surprise Percent
+21.16%

Description

⁨Aclaris Therapeutics⁩ (⁦ACRS⁩) has reported earnings of ⁦-0.12⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts